1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on September 17, 2025

Netflix upgraded, Five Below initiated: Wall Street's top analyst calls
ABBV

The Fly

3 hours ago

Netflix upgraded, Five Below initiated: Wall Street's top analyst calls

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker
ABBV

Investor's Business Daily

3 hours ago

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker

ABBV

MT Newswires

7 hours ago

Berenberg Upgrades AbbVie to Buy From Hold, Adjusts Price Target to $270 From $170

Guggenheim Reiterates a Buy Rating on AbbVie (ABBV), Sets a PT of $227
ABBV

Insider Monkey

a day ago

Guggenheim Reiterates a Buy Rating on AbbVie (ABBV), Sets a PT of $227

Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?
ABBV

Zacks

a day ago

Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?

AbbVie (ABBV)’s Dividend Track Record: How It Became a Leader in Consistent Dividends
ABBV

Insider Monkey

a day ago

AbbVie (ABBV)’s Dividend Track Record: How It Became a Leader in Consistent Dividends

Assessing AbbVie After Neuro Pipeline Expansion and Double Digit 2025 Share Gains
ABBV

Simply Wall St.

a day ago

Assessing AbbVie After Neuro Pipeline Expansion and Double Digit 2025 Share Gains

ABBV

MT Newswires

a day ago

JPMorgan Adjusts Price Target on AbbVie to $235 From $200, Maintains Overweight Rating

ABBV

MT Newswires

2 days ago

AbbVie Says Vraylar Antipsychotic Medication Now Listed on Alberta's Health Drug Formulary

ABBV

MT Newswires

2 days ago

Deutsche Bank Adjusts Price Target on AbbVie to $204 From $173

AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta
ABBV

CNW Group

2 days ago

AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta

Saisei Ventures Appoints James Feliciano as Venture Partner
ABBV

Business Wire

2 days ago

Saisei Ventures Appoints James Feliciano as Venture Partner

ABBV

MT Newswires

2 days ago

Cantor Fitzgerald Adjusts AbbVie Price Target to $245 From $215, Maintains Overweight Rating

ABBV

MT Newswires

2 days ago

Deutsche Bank Adjusts AbbVie Price Target to $204 From $173, Maintains Hold Rating

3 No-Brainer Dividend Stocks to Buy in September
ABBV

Motley Fool

4 days ago

3 No-Brainer Dividend Stocks to Buy in September

AbbVie Shares Hit Record High on Rinvoq Exclusivity Extension to 2037
ABBV

GuruFocus.com

5 days ago

AbbVie Shares Hit Record High on Rinvoq Exclusivity Extension to 2037

AbbVie settles litigation with all generic manufacturers of Rinvoq
ABBV

TipRanks

5 days ago

AbbVie settles litigation with all generic manufacturers of Rinvoq

AbbVie extends Rinvoq exclusivity by four years after generics settlements
ABBV

Pharmaceutical Technology

5 days ago

AbbVie extends Rinvoq exclusivity by four years after generics settlements

ABBV

MT Newswires

5 days ago

AbbVie Settles Lawsuit With Generic Producers of Upadacitinib

ABBV

MT Newswires

5 days ago

BMO Capital Adjusts Price Target on AbbVie to $240 From $215, Maintains Outperform Rating

ABBV

MT Newswires

5 days ago

Wells Fargo Adjusts Price Target on AbbVie to $260 From $240, Maintains Overweight Rating

The Best Stocks to Invest $50,000 In Right Now
ABBV

Motley Fool

5 days ago

The Best Stocks to Invest $50,000 In Right Now

ABBV

Morningstar Research

6 days ago

Analyst Report: AbbVie Inc.

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.
ABBV

Barrons.com

6 days ago

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.

Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More
ABBV

GlobeNewswire

7 days ago

Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche
ABBV

GlobeNewswire

7 days ago

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal
ABBV

Zacks

8 days ago

LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories
ABBV

PR Newswire

8 days ago

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

This 3 Stock Portfolio Provides Monthly Income
ABBV

Zacks

9 days ago

This 3 Stock Portfolio Provides Monthly Income

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
ABBV

Zacks

9 days ago

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts

Investing in Oncology: 3 Cancer Stocks With Promising Pipelines
ABBV

Zacks

9 days ago

Investing in Oncology: 3 Cancer Stocks With Promising Pipelines

J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?
ABBV

Zacks

9 days ago

J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?

ABBV

Argus Research

9 days ago

Weekly Stock List

1 Reason Every Investor Should Know About AbbVie (ABBV)
ABBV

Motley Fool

9 days ago

1 Reason Every Investor Should Know About AbbVie (ABBV)

3 Dividend Stocks to Double Up on Right Now
ABBV

Motley Fool

10 days ago

3 Dividend Stocks to Double Up on Right Now

AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders
ABBV

Simply Wall St.

11 days ago

AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders

3 Stocks to Buy and Hold Forever
ABBV

Motley Fool

11 days ago

3 Stocks to Buy and Hold Forever

AbbVie Declares Quarterly Dividend
ABBV

PR Newswire

12 days ago

AbbVie Declares Quarterly Dividend

Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?
ABBV

Zacks

13 days ago

Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?

AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial
ABBV

Clinical Trials Arena

13 days ago

AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial

Anti-Parkinson's Drugs Global Market Research Report 2025-2030 | $9.2 Bn Opportunities Driven by Increased Awareness in Emerging Countries and a Robust Pipeline of Innovations
ABBV

GlobeNewswire

13 days ago

Anti-Parkinson's Drugs Global Market Research Report 2025-2030 | $9.2 Bn Opportunities Driven by Increased Awareness in Emerging Countries and a Robust Pipeline of Innovations

Health Canada approves AbbVie’s Elahere for ovarian cancer
ABBV

Pharmaceutical Technology

13 days ago

Health Canada approves AbbVie’s Elahere for ovarian cancer

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
ABBV

Motley Fool

13 days ago

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals
ABBV

Simply Wall St.

14 days ago

AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals

ABBV

MT Newswires

14 days ago

AbbVie Says Updated Trial Data Suggest Treatment of R/R DLBCL With Epcoritamab Can Be Safe in Outpatient Setting

AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
ABBV

PR Newswire

14 days ago

AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
ABBV

PR Newswire

14 days ago

Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers

ABBV

MT Newswires

15 days ago

AbbVie Says Health Canada Approves Elahere in Some Types of Ovarian Cancers

Health Canada Approves ELAHERE® for Certain Types of Platinum-Resistant Ovarian Cancers
ABBV

CNW Group

15 days ago

Health Canada Approves ELAHERE® for Certain Types of Platinum-Resistant Ovarian Cancers

Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales
ABBV

Zacks

15 days ago

Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales

GSK Adds Around $5B in a Month: Here's How to Play the Stock
ABBV

Zacks

15 days ago

GSK Adds Around $5B in a Month: Here's How to Play the Stock

AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
ABBV

PR Newswire

15 days ago

AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access
ABBV

Insider Monkey

15 days ago

Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access

AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market
ABBV

Insider Monkey

15 days ago

AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market

Investing in the Age of Longevity: Silver Economy Stocks in Focus
ABBV

Zacks

16 days ago

Investing in the Age of Longevity: Silver Economy Stocks in Focus

Pfizer's Golden Cross Signals Strength: How to Play the Stock
ABBV

Zacks

16 days ago

Pfizer's Golden Cross Signals Strength: How to Play the Stock

Is AbbVie Stock Underperforming the S&P 500?
ABBV

Barchart

16 days ago

Is AbbVie Stock Underperforming the S&P 500?

AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work
ABBV

PR Newswire

17 days ago

AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work

ABBV

Market Exclusive

17 days ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
ABBV

Motley Fool

17 days ago

5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer

The Smartest Dividend Stocks to Buy With $500 Right Now
ABBV

Motley Fool

18 days ago

The Smartest Dividend Stocks to Buy With $500 Right Now

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?
ABBV

Zacks

19 days ago

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
ABBV

Zacks

19 days ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

ABBV

MT Newswires

19 days ago

DBS Bank Adjusts Price Target on AbbVie to $208 From $188, Maintains Hold Rating

ABBV

Pharmaceutical Technology

19 days ago

Health Canada issues NOC to AbbVie’s upadacitinib for giant cell arteritis

Assessing AbbVie’s Valuation After $1.2B Bretisilocin Acquisition Announcement
ABBV

Simply Wall St.

19 days ago

Assessing AbbVie’s Valuation After $1.2B Bretisilocin Acquisition Announcement

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma
ABBV

Insider Monkey

19 days ago

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally
ABBV

Insider Monkey

19 days ago

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

2 Reasons to Watch ABBV and 1 to Stay Cautious
ABBV

StockStory

20 days ago

2 Reasons to Watch ABBV and 1 to Stay Cautious

These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth
ABBV

Barchart

20 days ago

These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth

Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.
ABBV

Barrons.com

20 days ago

Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.

What Is the Intent Behind AbbVie's Recent Acquisition Spree?
ABBV

Zacks

21 days ago

What Is the Intent Behind AbbVie's Recent Acquisition Spree?

RINVOQ® (upadacitinib) Receives Health Canada Notice of Compliance (NOC) for Giant Cell Arteritis in adults
ABBV

CNW Group

21 days ago

RINVOQ® (upadacitinib) Receives Health Canada Notice of Compliance (NOC) for Giant Cell Arteritis in adults

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic
ABBV

GlobeNewswire

21 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

ABBV

Argus Research

22 days ago

The Argus High-Yield Model Portfolio

AbbVie’s (ABBV) Fell in Line with the Broader Biopharmaceutical Industry
ABBV

Insider Monkey

22 days ago

AbbVie’s (ABBV) Fell in Line with the Broader Biopharmaceutical Industry

ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression
ABBV

Zacks

22 days ago

ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

AbbVie agrees to acquire Gilgamesh’s bretisilocin for $1.2bn
ABBV

Pharmaceutical Technology

22 days ago

AbbVie agrees to acquire Gilgamesh’s bretisilocin for $1.2bn

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030
ABBV

GlobeNewswire

22 days ago

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

AbbVie dives back into the neuro pool with a $1.2B psychedelics play
ABBV

Pharma Voice

22 days ago

AbbVie dives back into the neuro pool with a $1.2B psychedelics play

How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock
ABBV

Benzinga

23 days ago

How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock

ABBV

MT Newswires

23 days ago

Sector Update: Health Care Stocks Fall Late Afternoon

ABBV

MT Newswires

23 days ago

Sector Update: Health Care Stocks Fall Monday Afternoon

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
ABBV

PR Newswire

23 days ago

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

AbbVie (ABBV): Evaluating Valuation as Rinvoq Achieves Phase 3 Success in Severe Alopecia Areata
ABBV

Simply Wall St.

23 days ago

AbbVie (ABBV): Evaluating Valuation as Rinvoq Achieves Phase 3 Success in Severe Alopecia Areata

3 Unstoppable Dividend Stocks to Buy Right Now
ABBV

Motley Fool

25 days ago

3 Unstoppable Dividend Stocks to Buy Right Now

JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9
ABBV

Insider Monkey

25 days ago

JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth
ABBV

Zacks

a month ago

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth
ABBV

Zacks

a month ago

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

AbbVie seeks Rinvoq alopecia approval after second Phase III success
ABBV

Clinical Trials Arena

a month ago

AbbVie seeks Rinvoq alopecia approval after second Phase III success

The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil and AbbVie
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil and AbbVie

AbbVie's Rinvoq Shines In Hair Loss Trial
ABBV

GuruFocus.com

a month ago

AbbVie's Rinvoq Shines In Hair Loss Trial

Top Stock Reports for Alphabet, Exxon Mobil & AbbVie
ABBV

Zacks

a month ago

Top Stock Reports for Alphabet, Exxon Mobil & AbbVie

AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study
ABBV

Simply Wall St.

a month ago

AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study

ABBV

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
ABBV

GlobeNewswire

a month ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
ABBV

Benzinga

a month ago

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
ABBV

PR Newswire

a month ago

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer
ABBV

Motley Fool

a month ago

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer

Does AbbVie's US$10 Billion U.S. Manufacturing Bet Shift the Long-Term Outlook for ABBV?
ABBV

Simply Wall St.

a month ago

Does AbbVie's US$10 Billion U.S. Manufacturing Bet Shift the Long-Term Outlook for ABBV?

Share on Social Networks: